Dehydroepiandrosterone inhibits lipopolysaccharide-induced nitric oxide production in BV-2 microglia

Journal of Neurochemistry

Volumn 77, Issue 3, 2001, Pages 830-838

  Wang, Mei Jen ^a   Huang, Hsueh Meei ^a   Chen, Huan Lian ^a   Kuo, Jon Son ^a   Jeng, Kee Ching G ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Dehydroepiandrosterone; Inducible nitric oxide synthase; Lipopolysaccharide; Microglia

Indexed keywords

DACTINOMYCIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PRASTERONE; PRASTERONE SULFATE;

AGING; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASTROCYTE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GLIA CELL; LEARNING; MEMORY; MICROGLIA; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; CELL LINE, TRANSFORMED; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; GENE EXPRESSION; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

ANIMALIA;

EID: 0034999857     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00295.x     Document Type: Article

References (62)

1. Adams J., Garcia M. and Rochefort H. (1981) Estrogenic effects of physiological concentrations of 5-androstene-3 beta, 17 beta-diol and its metabolism in MCF7 human breast cancer cells. Cancer Res. 41, 4720-4726.
2. Aragno M., Brignardello E., Tamagno E., Gatto V., Danni O. and Boccuzzi G. (1997) Dehydroepiandrosterone administration prevents the oxidative damage induced by acute hyperglycemia in rats. J. Endocrinol. 155, 233-240.
3. Baichwal V. R. and Baeuerle P. A. (1997) Activate NF-kappa B or die? Curr. Biol. 7, R94-R96.
4. Barens P. J. and Adcock I. (1993) Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol. Sci. 14, 436-441.
5. Bastianetto S., Ramassamy C., Poirier J. and Quirion R. (1999) Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Mol. Brain Res. 66, 35-41.
6. Baulieu E. E. (1981) Steroid hormones in the brain: several mechanisms?, in Steroid Hormone Regulation of the Brain (Fuxe K., Gustafson J. A. and Wettenberg L., eds), pp. 3-14. Pergamon, Oxford.
7. Baulieu E. E. and Robel P. (1996) Dehydroepiandrosterone and Dehydroepiandrosterone sulfate as neuroactive neurosteroids. J. Endocrinol. 150, S221-S239.
8. Behl C., Skutella T., Lezoualc'h F., Post A., Widmann M., Newton C. J. and Holsboer F. (1997) Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol. Pharmacol. 51, 535-541.
9. Ben-Nathan D., Lachmi B., Lustig S. and Feursfein G. (1991) Protection of dehydroepiandrosterone in mice infected with viral encephalitis. Arch. Virol. 120, 263-271.
10. Blasi E., Barluzzi R., Bocchini V., Mazzolla R. and Bistoni F. (1990) Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J. Neuroimmunol. 27, 229-237.
11. Boccuzzi G., Aragno M., Seccia M., Brignardello E., Tamagno E., Albano E., Danni O. and Bellomo G. (1997) Protective effect of Dehydroepiandrosterone against copper-induced lipid peroxidation in the rat. Free Radic. Biol. Med. 22, 1289-1294.
12. Brown R. C., Cascio C. and Papadopoulos V. (2000) Pathways of neurosteroid biosynthesis in cell lines from human brain: regulation of dehydroepiandrosterone formation by oxidative stress and β-amyloid peptide. J. Neurochem. 74, 847-859.
13. Bruder J. M., Sobek L. and Oettel M. (1997) Dehydroepiandrosterone stimulates the estrogen response element. J. Steroid Biochem. Mol. Biol. 62, 461-466.
14. Camhi S. L., Alam J., Wiegand G. W., Chin B. Y. and Choi A. M. K. (1998) Transcriptional activation of the HO-1 gene by lipopolysaccharide is mediated by 5′ distal enhancers: role of reactive oxygen intermediates and AP-1. Am. J. Respir. Cell Mol. Biol. 18, 226-234.
15. Chao C. C., Hu S., Molitor T. W., Shaskan E. G. and Peterson P. K. (1992) Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149, 2736-2741.
16. Danenberg H. D., Alpert G., Lustig S. and Ben-Nathan D. (1992) Dehydroepiandrosterone protects mice from endotoxin toxicity and reduces tumor necrosis factor production. Antimicrob. Agents Chemother. 36, 2275-2279.
17. 40 and lipopolysaccharides. J. Neurochem. 73, 1453-1460.
18. Galea E., Feinstein D. L. and Reis D. J. (1992) Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. Proc. Natl. Acad. Sci. USA 89, 10945-10949.
19. Garcia-Estrada J., Luquin S., Fernandez A. M. and Garcia-Segura L. M. (1999) Dehydroepiandrosterone, pregnenolone and sex steroids down-regulate reactive astroglia in the male rat brain after a penetrating brain injury. Int. J Dev. Neurosci. 17, 145-151.
20. Hewett S. J., Csernansky C. A. and Choi D. W. (1994) Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS. Neuron 13, 487-494.
21. Hu J. and Van Eldik L. J. (1996) S100β induces apoptotic cell death in cultured astrocytes via a nitric oxide-dependent pathway. Biochim. Biophys. Acta 1313, 239-245.
22. Hu J., Akama K. T., Krafft G. A., Chromy B. A. and Van-Eldik L. J. (1998) Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release. Brain Res. 785, 195-206.
23. Itagaki S., McGeer P. L., Akiyama H., Zhu S. and Selkoe D. (1989) Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J. Neuroimmunol. 24, 173-182.
24. Jonat C., Rahmsdorf H. J., Park K., -K., Cato A. C., Gebel S., Ponta H. and Herrlich P. (1990) Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62, 1189-1204.
25. Kauser K., Sonnenberg D., Diel P. and Rubanyi G. M. (1998) Effect of 17β-oestradiol on cytokine-induced nitric oxide production in rat isolated aorta. Br. J. Pharmacol. 123, 1089-1096.
26. Kern J. A., Lamb R. J., Reed J. C., Daniele R. P. and Nowell P. C. (1988) Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms. J. Clin. Invest. 81, 237-244.
27. Kimonides V. G., Khatibi N. H., Svendsen C. N., Sofroniew M. V. and Herbert J. (1998) Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc. Natl. Acad. Sci. USA 95, 1852-1857.
28. Kipper-Galperin M., Galilly R., Danenberg H. D. and Brenner T. (1999) Dehydroepiandrosterone selectively inhibits production of tumor necrosis factor α and interleukin-6 in astrocytes. Int. J. Dev. Neurosci. 17, 765-775.
29. Lacroix C., Fiet J., Benais J., -P., Gueux B., Bonete R., Villette J., -M., Gourmel B. and Dreux C. (1987) Simultaneous radioimmunoassay of progesterone, andros-4-enedione, pregnenolone, dehydroepiandrosterone and 17-hydroxyprogesterone in specific regions of human brain. J. Steroid Biochem. 28, 317-325.
30. A receptors. Stroke 31, 1953-1957.
31. Laychock S. G. (1998) Rat pancreatic islet and RINm5F cell responses to epiandrosterone, dehydroepiandrosterone and interleukin-1β. Biochem. Pharmacol. 55, 1453-1464.
32. Loria R. M., Inge T. H., Cook S., Szakal A. and Regelson W. (1988) Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone (DHEA). J. Med. Virol. 26, 301-314.
33. McGeer P. L., Itagaki S., Boyes B. E. and McGeer E. G. (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38, 1285-1291.
34. McLachlan J. A., Serkin C. D. and Bakouche O. (1996) Dehydroepiandrosterone modulation of lipopolysaccharide-stimulated monocyte cytotoxicity. J. Immunol. 156, 328-335.
35. Marks P. A. and Banks J. (1960) Inhibition of mammalian glucose-6-phosphate dehydrogenase by steroids. Proc. Natl. Acad. Sci. USA 46, 447-452.
36. Matsumoto Y., Ohmori K. and Fujiwara M. (1992) Microglial and astroglial reactions to inflammatory lesions of experimental autoimmune encephalomyelitis in the rat central nervous system. J. Neuroimmunol. 37, 23-33.
37. Meikle A. W., Douhuck R. W., Araneo B. A., Stringham J. D., Evans T. G., Spruance S. L. and Daynes R. A. (1992) The presence of a Dehydroepiandrosterone-specific receptor binding complex in murine T cells. J. Steroid Biochem. Mol. Biol. 42, 293-304.
38. Merrill J. E. and Benveniste E. N. (1996) Cytokines in inflammatory brain lesions: helpful and harmful. TINS 19, 331-338.
39. Merrill J. E. and Chen I. S. (1991) HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J. 5, 2391-2397.
40. Miyamoto N., Mandai M., Suzuma I., Suzuma K., Kobayashi K. and Honda Y. (1999) Estrogen protects against cellular infiltration by reducing the expressions of E-selectin and IL-6 in endotoxin-induced uveitis. J. Immunol. 163, 374-379.
41. Mohan P. F. and Jacobson M. S. (1993) Inhibition of macrophage superoxide generation by dehydroepiandrosterone. Am. J. Med. Sci. 306, 10-15.
42. Moncada S., Palmer R. M. J. and Higgs E. A. (1991) Nitric oxide: physiology, pathology, and pharmacology. Pharmacol. Rev. 43, 109-142.
43. Okabe T., Haji M., Takayanagi R., Adachi M., Imasaki K., Kurimoto F., Watanabe T. and Nawata H. (1995) Up-regulation of high-affinity dehydroepiandrosterone binding activity by dehydroepiandrosterone in activated human T lymphocytes. J. Clin. Endocrinol. Metab. 80, 2993-2996.
44. Orentreich N., Brind J. L., Vogelman J. H., Andres R. and Baldwin H. (1992) Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal man. J. Clin. Endocrinol. Metab. 75, 1002-1004.
45. Padgett D. A. and Loria R. M. (1998) Endocrine regulation of murine macrophage function: effects of dehydroepiandrosterone, androstenediol, and androstenetriol. J. Neuroimmunol. 84, 61-68.
46. Palmer H. J. and Paulson K. E. (1997) Reactive oxygen species and antioxidants in signal transduction and gene expression. Nutr. Rev. 55, 353-361.
47. Perry V. H. and Gordon S. (1988) Macrophages and microglia in the nervous system. Trends Neurosci. 11, 273-277.
48. 2. Proc. Natl. Acad. Sci. USA 96, 4668-4673.
49. 2: differential effects on endotoxin-stimulated cytokine induction. J. Biol. Chem. 274, 28823-28827.
50. Poortman J., Prenen J. A., Schwarz F. and Thijssen J. H. (1975) Interaction of delta-5-androstene-3 beta, 17 beta-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue. J. Clin. Endocrinol. Metab. 40, 373-379.
51. Raineri R. and Levy H. R. (1990) On the specificity of steroid interaction with mammary glucose-6-phosphate dehydrogenase. Biochemistry 9, 2233-2243.
52. Sankarapandi S., Zweier J. L., Mukherjee G., Quinn M. T. and Huso D. L. (1998) Measurement and characterization of superoxide generation in microglial cells: evidence for an NADPH oxidase-dependent pathway. Arch. Biochem. Biophys. 353, 312-321.
53. Scheinman R. I., Gualberto A., Jewell C. M., Cidlowski J. A. and Baldwin A. S. Jr (1995) Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol. Cell. Biol. 15, 943-953.
54. Schreck R., Rieber P. and Baeuerle P. A. (1991) Reactive oxygen intermediates as apparent widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10, 2247-2258.
55. Simmons M. L. and Murphy S. (1992) Induction of nitric oxide synthase in glial cells. J. Neurochem. 59, 897-905.
56. Walker G., Pfeilschifter J. and Kunz D. (1996) Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-γ-stimulated RAW 264.7 cells by dexamethasone. J. Biol. Chem. 271, 16679-16687.
57. Wang M. J., Huang H. M., Hsieh S. J., Jeng K. C. G., Kuo J. S., (2001) Resveratrol inhibits interleukin-6 production in cortical mixed glial cells under hypoxia/hypoglycemia followed by reoxygenation. J. Neuroimmunol. 112, 28-34.
58. Weldon D. T., Rogers S. D., Ghilardi J. R., Finke M. P., Cleary J. P., O'Hare E., Esler W. P., Maggio J. E. and Mantyh P. W. (1998) Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J. Neurosci. 18, 2161-2173.
59. Whitcomb J. M. and Schwartz A. G. (1985) Dehydroepiandrosterone and 16 alpha-Br.-epiandrosterone inhibit 12-O-tetradecanoylphorbol-13-acetate stimulation of superoxide radical production by human polymorphonuclear leukocytes. Carcinogenesis 6, 333-335.
60. Wolf O. T. and Kirschbaum C. (1999) Actions of Dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans. Brain Res. Rev. 30, 264-288.
61. Zwain I. H. and Yen S. S. C. (1999a) Dehydroepiandrosterone: biosynthesis and metabolism in the brain. Endocrinology 140, 880-887.
62. Zwain I. H. and Yen S. S. C. (1999b) Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology 140, 3843-3852.